The tweet was deleted by the author.
But we saved everything 🙂.
Patrick Soon-Shiong, a prominent figure in medical research and innovation, has highlighted promising developments in the treatment of aggressive cancers, including triple negative breast cancer.
On a recent Twitter post, Soon-Shiong emphasized the significance of achieving ''long-term memory'' in such aggressive tumors. According to him, this advancement has shown extended remission periods in cancers like pancreatic, bladder, and lung. The approach involves maintaining absolute lymphocyte count (ALC) as an adjunct to modified current therapies.
This breakthrough is part of an ongoing effort to refine cancer treatments and improve patient outcomes. The implications of these findings suggest a shift in how long-term cancer remission might be approached, potentially offering hope to many patients battling these aggressive forms of cancer.
These developments align with broader conversations about the dangers of lymphopenia and Anktiva's potential benefits, topics previously explored in depth through Patrick Soon-Shiong's work with leading medical institutions. The renewed focus on cancer remission strategies further recalls efforts urging national initiatives to advance the Cancer Moonshot, underscoring the sustained impact of continued innovation in oncology.